Showing posts with label liraglutide. Show all posts
Showing posts with label liraglutide. Show all posts

Sunday 22 December 2013

Novo Nordisk Files NDA, MAA for Victoza for Obesity

Novo Nordisk files for regulatory approval of liraglutide 3 mg for the treatment of obesity 
Bagsværd, Denmark, 20 December 2013 – Novo Nordisk today announced two separate regulatory submissions for a 3 mg dose of liraglutide, a once-daily human GLP-1 analogue, as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity, or who are overweight with comorbidities. The company filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) with the European Medicines Agency (EMA).http://www.pharmalive.com/novo-nordisk-files-nda-maa-for-victoza-for-obesity